![Mixed connective tissue disease (MCTD), means that a person has more than one of the other CTDs like lupus, Sjogren'… | Raynaud's disease, Lupus, Autoimmune disease Mixed connective tissue disease (MCTD), means that a person has more than one of the other CTDs like lupus, Sjogren'… | Raynaud's disease, Lupus, Autoimmune disease](https://i.pinimg.com/474x/b5/dd/f7/b5ddf761c9ce52b68799e731f7f936d5.jpg)
Mixed connective tissue disease (MCTD), means that a person has more than one of the other CTDs like lupus, Sjogren'… | Raynaud's disease, Lupus, Autoimmune disease
Autoimmune Disease List - Mixed connective tissue disease is classified and considered as an “overlap” of three diseases, Systemic Lupus Erythematosus, Scleroderma, and Polymyositis. | Facebook
![Overlap Syndromes, Mixed Connective Tissue Disease, and Undifferentiated Connective Tissue Disease | Musculoskeletal Key Overlap Syndromes, Mixed Connective Tissue Disease, and Undifferentiated Connective Tissue Disease | Musculoskeletal Key](https://i1.wp.com/musculoskeletalkey.com/wp-content/uploads/2018/07/B978032304434950049X_gr2.jpg?w=960)
Overlap Syndromes, Mixed Connective Tissue Disease, and Undifferentiated Connective Tissue Disease | Musculoskeletal Key
![Mixed Connective Tissue Disease (MCTD) - Bone, Joint, and Muscle Disorders - Merck Manuals Consumer Version Mixed Connective Tissue Disease (MCTD) - Bone, Joint, and Muscle Disorders - Merck Manuals Consumer Version](https://www.merckmanuals.com/-/media/manual/home/images/4/2/r/42-raynaud-slide-4-springer-high-higher.jpg?mw=350&thn=0&sc_lang=en)
Mixed Connective Tissue Disease (MCTD) - Bone, Joint, and Muscle Disorders - Merck Manuals Consumer Version
![Figure 2 from The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease | Semantic Scholar Figure 2 from The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bc35478863005bcc9f3fecfebbe3baf979d680b2/5-Figure2-1.png)